Rathbones Group’s NxStage Medical Inc. NXTM Stock Holding History

Rathbones Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,300	Closed	-$266K	–	332
2018 Q4	$266K	Hold	9,300	–	–	0.01%	265
2018 Q3	$259K	Sell	9,300 -1,500	-14%	-$42.2K	0.01%	264
2018 Q2	$301K	Hold	10,800	–	–	0.01%	243
2018 Q1	$268K	Hold	10,800	–	–	0.01%	258
2017 Q4	$262K	Hold	10,800	–	–	0.01%	268
2017 Q3	$298K	Buy	10,800 +600	+6%	+$16K	0.01%	248
2017 Q2	$256K	Hold	10,200	–	–	0.01%	257
2017 Q1	$274K	Hold	10,200	–	–	0.01%	257
2016 Q4	$267K	Hold	10,200	–	–	0.01%	251
2016 Q3	$255K	Hold	10,200	–	–	0.01%	261
2016 Q2	$221K	Hold	10,200	–	–	0.01%	266
2016 Q1	$153K	Hold	10,200	–	–	0.01%	282
2015 Q4	$194K	Hold	10,200	–	–	0.01%	268
2015 Q3	$161K	Hold	10,200	–	–	0.01%	282
2015 Q2	$146K	Buy	+10,200	New	+$173K	0.01%	299

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Rathbones Group's NXTM Position: Q1 2019 in Review

Rathbones Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 9,300 shares — an estimated $266K sold.

Rathbones Group first reported a position in NXTM in Q2 2015 and held it in 15 quarters. The position peaked at $301K in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Rathbones Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Rathbones Group sold 9,300 NxStage Medical Inc. shares in Q1 2019, an estimated $266K.
Rathbones Group first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 15 quarters.
Rathbones Group's NxStage Medical Inc. position peaked at $301K in Q2 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Rathbones Group's 13F filing for Q1 2019, filed 9 May 2019.